5 Indian scientists selected as members of EMBO Global Investigator Network
New Delhi, Dec 13 (IANS) The European Molecular Biology Organisation (EMBO) has selected 11 life scientists as newest members of the EMBO Global Investigator Network and five of them are from India, the government said on Friday. Among the five Indian scientists, two are from the Regional Centre for Biotechnology (RCB), Faridabad – associate professors
New Delhi, Dec 13 (IANS) The European Molecular Biology Organisation (EMBO) has selected 11 life scientists as newest members of the EMBO Global Investigator Network and five of them are from India, the government said on Friday.
Among the five Indian scientists, two are from the Regional Centre for Biotechnology (RCB), Faridabad – associate professors Dr Prem Kaushal and Dr Rajender Motiani.
While Dr Kaushal’s research focuses on protein synthesis in pathogenic microbes, Mycobacterium tuberculosis and Entamoeba histolytica, Dr Motiani’s research programme focuses on understanding the role of calcium driven inter-organelle crosstalk in skin pigmentation.
“I look forward to engaging and networking with some of the brightest life science researchers across the globe,” said Dr Motiani.
Dr Kaushal remarked, “I am grateful to EMBO for recognising our research work. It will help establish international collaborations and bring new technologies to the Regional Centre for Biotechnology.”
The EMBO Global Investigator Network supports young group leaders in Chile, India, Singapore and Taiwan.
The new global investigators will become part of an international network of nearly 800 current and former EMBO Global Investigators, Young Investigators and Installation Grantees, and will start in January 2025, according to Ministry of Science and Technology.
“We are excited to welcome the new EMBO Global Investigators. Their research highlights the universal language of discovery and provides diverse perspectives to tackle foundational research questions as well as global challenges,” said EMBO Director Professor Fiona Watt.
“We are delighted to support these outstanding group leaders in forming connections with scientists in Europe and around the world,” Watt added.
The new global investigators receive financial support for four years for networking activities and collaborations with local scientists and those in Europe.
RCB is an academic institution established by the Department of Biotechnology with regional and global partnerships synergising with the programmes of UNESCO as a Category II Centre.
–IANS
na/
Badminton High Performance Centre Inaugurated at Kalinga Stadium
Next ArticleOdisha: Vigilance Dept arrests three including govt official in Rs 4 crore misappropriation case
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

Health & LifestyleGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
